Dr. Gitlitz on EGFR Exon 20 Insertion Mutations in Lung Cancer

EGFR Mutations in Patients With Lung CancerПодробнее

Dr. Gitlitz Discusses The Genomics of Young Lung Cancer StudyПодробнее

EGFR Exon-20 Mutation - Lung Cancer Video LibraryПодробнее

EGFR Exon 20 Mutations in Non–Small Cell Lung CancerПодробнее

Exon 20 insertions in NSCLC - ESMO 2020Подробнее

Burden of EGFR Exon 20 Mutation in NSCLCПодробнее

Targeted treatments for EGFR exon 20 insertion mutations in NSCLCПодробнее

Treating Non–Small Cell Lung Cancer With an EGFR Exon 20 InsertionПодробнее

Anti-tumour activity of TAK-788 in NSCLC patients with EGFR exon 20 insertionsПодробнее

Latest in EGFR-positive NSCLC with exon 20 insertion mutationsПодробнее

Targeted Therapy in EGFR Exon 20-Mutant Non–Small Cell Lung CancerПодробнее

Pasi Jänne, MD, PhD, elaborates on EGFR exon 20 insertions in non-small cell lung cancerПодробнее

Current treatments and challenges for patients with EGFR exon 20 insertion-positive NSCLCПодробнее

Real world data and diagnostics in patients with NSCLC with EGFR exon 20 insertionsПодробнее

Tackling EGFR Exon 20 Mutations: Clinical Challenges, New Insights Part 1Подробнее

How do doctors treat lung cancer with EGFR mutations?Подробнее

Case Based Panel Discussion - EGFR - Exon 20 Mutation, Treatment, Targeted Therapy, Clinical TrialsПодробнее

Managing patients with EGFR exon 20 ins in NSCLC and EGFR TKI toxicityПодробнее

Dr Omshree Shetty - Interpretation Of Exon 20 InsertionПодробнее